ArticleFrontiers in immunology2023

Mitochondrial DNA methylation is a predictor of immunotherapy response and prognosis in breast cancer: scRNA-seq and bulk-seq data insights.

Yixuan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.